Wells Fargo & Company Ocular Therapeutix, Inc Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Ocular Therapeutix, Inc stock. As of the latest transaction made, Wells Fargo & Company holds 456,426 shares of OCUL stock, worth $3.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
456,426
Previous 51,319 789.39%
Holding current value
$3.9 Million
Previous $351,000 1031.05%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$6.45 - $9.23 $2.61 Million - $3.74 Million
405,107 Added 789.39%
456,426 $3.97 Million
Q2 2024

Aug 13, 2024
BUY
$4.2 - $8.69 $64,176 - $132,783
15,280 Added 42.4%
51,319 $351,000
Q1 2024

May 10, 2024
BUY
$3.85 - $10.93 $53,268 - $151,227
13,836 Added 62.32%
36,039 $327,000
Q4 2023

Feb 09, 2024
BUY
$2.08 - $4.52 $10,562 - $22,952
5,078 Added 29.65%
22,203 $99,000
Q3 2023

Nov 13, 2023
SELL
$3.14 - $5.04 $54,598 - $87,635
-17,388 Reduced 50.38%
17,125 $53,000
Q2 2023

Aug 15, 2023
BUY
$4.6 - $7.64 $76,930 - $127,771
16,724 Added 94.01%
34,513 $178,000
Q1 2023

May 12, 2023
BUY
$2.79 - $6.27 $44,190 - $99,310
15,839 Added 812.26%
17,789 $93,000
Q4 2022

Feb 13, 2023
SELL
$2.61 - $4.41 $11,906 - $20,118
-4,562 Reduced 70.06%
1,950 $5,000
Q3 2022

Nov 14, 2022
SELL
$4.09 - $6.5 $2,474 - $3,932
-605 Reduced 8.5%
6,512 $27,000
Q2 2022

Aug 12, 2022
SELL
$3.01 - $5.22 $27,400 - $47,517
-9,103 Reduced 56.12%
7,117 $29,000
Q1 2022

May 16, 2022
SELL
$4.83 - $7.35 $124,691 - $189,747
-25,816 Reduced 61.41%
16,220 $80,000
Q4 2021

Feb 14, 2022
SELL
$6.16 - $12.07 $89,012 - $174,411
-14,450 Reduced 25.58%
42,036 $292,000
Q3 2021

Nov 15, 2021
SELL
$9.7 - $14.34 $153,502 - $226,930
-15,825 Reduced 21.88%
56,486 $565,000
Q2 2021

Aug 16, 2021
SELL
$13.43 - $19.16 $6.22 Million - $8.87 Million
-463,021 Reduced 86.49%
72,311 $1.03 Million
Q1 2021

May 13, 2021
BUY
$15.82 - $22.11 $3.68 Million - $5.14 Million
232,689 Added 76.89%
535,332 $8.79 Million
Q4 2020

Feb 09, 2021
BUY
$7.91 - $22.95 $1.07 Million - $3.12 Million
135,832 Added 81.43%
302,643 $6.26 Million
Q3 2020

Nov 05, 2020
BUY
$7.36 - $9.87 $725,784 - $973,300
98,612 Added 144.59%
166,811 $1.27 Million
Q2 2020

Aug 13, 2020
BUY
$4.67 - $8.95 $71,315 - $136,675
15,271 Added 28.85%
68,199 $568,000
Q1 2020

May 14, 2020
BUY
$3.95 - $7.4 $209,065 - $391,667
52,928 New
52,928 $262,000

Others Institutions Holding OCUL

# of Institutions
171
Shares Held
138M
Call Options Held
150K
Put Options Held
225K
View Full List

About OCULAR THERAPEUTIX, INC

OCUL Quotes by TradingView
  • Ticker OCUL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,966,896
  • Market Cap $657M
  • Description
  • Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...
More about OCUL
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email